Laurus Labs Ltd. (LAURUSLABS)
NSE
Closed
Sep 8, 2026
Day's Range
1,862.7052 wk Range
823.10Overview - LAURUSLABS - Laurus Labs Ltd.
Key Statistics
Valuation
Enterprise Value
1.06T
P/E (Trailing)
‪95.68‬
P/E (Forward)
‪68.59‬
PEG Ratio
‪1.68‬
Price / Sales (TTM)
‪14.40‬
Price / Book
‪19.74‬
EV / EBITDA
‪52.27‬
Profitability
Gross Margin
‪62.69%‬
Profit Margin
‪15.04%‬
Operating Margin
‪25.38%‬
Return on Assets
‪8.45%‬
Return on Equity
‪16.36%‬
Ownership
Shares Outstanding
540.31M
Float
363.42M
Held by Insiders
‪32.03%‬
Held by Institutions
‪32.58%‬
Price stats
Beta
‪0.35‬
50-Day Avg
‪1,664.11‬
200-Day Avg
‪1,246.69‬
Dividends
Payout Ratio
‪9.89%‬
Frequency
Semi-Annual
Analyst Consensus
15 analysts
Average price target
‪₹ 1,486.29‬Market Cap - LAURUSLABS - Laurus Labs Ltd.
Peers - LAURUSLABS - Laurus Labs Ltd.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on NSE.
- LAURUSLABSNSELaurus Labs Ltd.1.04TMarket Cap+55.80%52-week change95.68P/E (Trailing)‪15.04%‬Profit Margin
- DIVISLABNSEDivi's Laboratories Ltd.2.45TMarket Cap+34.05%52-week change95.31P/E (Trailing)‪26.04%‬Profit Margin
- CIPLANSECipla Ltd.1.14TMarket Cap-11.50%52-week change34.09P/E (Trailing)‪12.00%‬Profit Margin
- LUPINNSELupin Ltd.992.95BMarket Cap+12.96%52-week change18.10P/E (Trailing)‪18.45%‬Profit Margin
- DRREDDYNSEDr. Reddy's Laboratories Ltd.981.26BMarket Cap-8.65%52-week change29.70P/E (Trailing)‪9.99%‬Profit Margin
- MANKINDNSEMankind Pharma Ltd.953.72BMarket Cap-15.82%52-week change46.78P/E (Trailing)‪13.85%‬Profit Margin
- AUROPHARMANSEAurobindo Pharma Ltd.951.15BMarket Cap+37.08%52-week change25.98P/E (Trailing)‪10.62%‬Profit Margin
Profile Summary - LAURUSLABS - Laurus Labs Ltd.
About
Laurus Labs Ltd. is a prominent pharmaceutical company engaged in the manufacturing and commercialization of high-quality generic Active Pharmaceutical Ingredients (APIs), formulations, and specialty ingredients. The company's primary function is to provide affordable and effective pharmaceutical solutions to a…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
